You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and babies; and its Pediatrics products treat allergies, asthma, and attention deficit/hyperactivity disorder. Founded in 1992, Sciele Pharma employs more than 1,000 people. In October 2008, Shionogi & Co., Ltd. acquired Sciele, which now operates as an indirect wholly owned subsidiary of Shionogi.
Name changed to Shionogi Pharma, Inc. on January 12, 2010.
| Ticker: | SCRX |
| ISIN: | US8086271033 |
| Address: |
Five Concourse Parkway Suite 1800 |
| Atlanta, GA, 30328, USA | |
| Website: | Sciele Pharma, Inc. |
| Phone #: | (800) 461-3696 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Pharmaceutical & Medicine Manufacturing |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.